Centene Corporation
CNC
Positions held
Your positionsCNC isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- Centene Corporation operates in the growing healthcare plans industry, which is expected to expand due to increasing demand for healthcare services.
- Revenue increased by 7% compared to the prior quarter, reaching $53.6 billion.
- Despite a decrease in gross margin to 8.6%, the company maintains a forward P/E ratio of 12.08, indicating potential for future earnings growth.
- Centene's profit margin is currently negative at -2.83%, reflecting challenges in profitability.
- The company reported a net income loss of $6,674 million for the year 2025, indicating ongoing financial struggles.
- Operating margin has been fluctuating, with a negative operating margin of -2.48% in Q4 2025.
Fundamentals
| Market cap | $31.88B | Enterprise value | $21.03B | Trailing P/E | — | Forward P/E | 12.07 |
| PEG | 0.78 | Price / book | 1.41 | Beta | 1.13 | Dividend yield | 0.00% |
| Revenue growth | 4.6% | Earnings growth | — | Gross margin | 11.4% | Operating margin | 3.8% |
| Profit margin | -2.8% | ROE | -20.4% | ROA | 2.5% | Debt / equity | 0.71 |
| Current ratio | 1.15 | Free cash flow | $9.64B | Analyst recommendation | buy | Mean target | $71.78 |
| 52w high | $69.63 | 52w low | $31.63 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $53.6B | $49.9B | $49.7B | $49.7B | $48.7B | — |
| Op margin | 2.2% | 3.7% | -2.5% | -0.4% | -0.8% | — |
| Net income | $1.1B | $1.5B | -$1.1B | -$6.6B | -$253M | — |
| Gross margin | 8.6% | 11.1% | 5.0% | 6.5% | 6.0% | — |
| Gross profit | $4.6B | $5.6B | $2.5B | $3.3B | $2.9B | — |
| Operating income | $1.2B | $1.9B | -$1.2B | -$211M | -$403M | — |
- Revenue +7% vs prior quarter ($53.6B vs $49.9B).
- Gross margin 8.6% (was 11.1% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $194.8B | $163.1B | $154.0B | $144.5B | — |
| Op margin | -0.2% | 2.0% | 2.2% | 2.5% | — |
| Net income | -$6.7B | $3.3B | $2.7B | $1.2B | — |
| Gross margin | 7.1% | 10.3% | 11.2% | 11.5% | — |
| Gross profit | $13.9B | $16.8B | $17.3B | $16.7B | — |
| Operating income | -$312M | $3.2B | $3.5B | $3.6B | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Humana Leads Managed Care Peers in 2027 Medicare Advantage Star Ratings, Deutsche Bank Says
2026-10-09 · Is Clover Health Stock Too Dependent On One Group Of Members?
2026-10-08 · Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?
2026-10-08 · Earnings Preview: What to Expect From Centene's Report
2026-10-07 · Suze Orman Warned 390,000 People Their Medicare Plans Are Shutting Down, Then CNBC Called the Same Stock a Turnaround
2026-10-07 · Centene's Operations Improve: Does the 12.34X P/E Make it a Buy?
2026-10-07 · Centene to Offer Expanded Health Access to Eligible Ambetter Members
2026-10-07 · Ambetter Health Solutions and Marathon Health Expand Access to Primary Care for Members in Indiana and Missouri
2026-10-06 · Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated
2026-10-06 · Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3
2026-10-05 · Oscar Health Trading at a Premium: Why Should You Still Buy It?
2026-10-05 · UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure
Price (daily)
Full chart · RSI · MACD · patternsOn Trade and Ticker